Selecting lung transplant candidates: where do current guidelines fall short?

References

• Unilateral lung transplantation for pulmonary fibrosis. Toronto Lung Transplant Group. N. Engl. J. Med.314(18), 1140–1145 (1986).
   PubMed Web of Science ®Google Scholar
• Grossman RF, Frost A, Zamel N et al. Results of single-lung transplantation for bilateral pulmonary fibrosis. The Toronto Lung Transplant Group. N. Engl. J. Med.322(11), 727–733 (1990).
   PubMed Web of Science ®Google Scholar
• Christie JD, Edwards LB, Kucheryavaya AY et al. The Registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult lung and heart-lung transplant report – 2010. J. Heart Lung Transplant.29(10), 1104–1118 (2010).
   PubMed Web of Science ®Google Scholar
• Orens JB, Estenne M, Arcasoy S et al. International guidelines for the selection of lung transplant candidates: 2006 update – a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. J. Heart Lung Transplant.25(7), 745–755 (2006).
   PubMed Web of Science ®Google Scholar
• Egan TM, Murray S, Bustami RT et al. Development of the new lung allocation system in the United States. Am. J. Transplant.6(5 Pt 2), 1212–1227 (2006).
   PubMed Web of Science ®Google Scholar
• Yusen RD, Shearon TH, Qian Y et al. Lung transplantation in the United States, 1999–2008. Am. J. Transplant.10(4 Pt 2), 1047–1068 (2010).
   PubMed Web of Science ®Google Scholar
• Liu V, Zamora MR, Dhillon GS, Weill D. Increasing lung allocation scores predict worsened survival among lung transplant recipients. Am. J. Transplant.10(4), 915–920 (2010).
   PubMed Web of Science ®Google Scholar
• Merlo CA, Weiss ES, Orens JB et al. Impact of U.S. Lung Allocation Score on survival after lung transplantation. J. Heart Lung Transplant.28(8), 769–775 (2009).
   PubMed Web of Science ®Google Scholar
• Weiss ES, Allen JG, Merlo CA, Conte JV, Shah AS. Lung allocation score predicts survival in lung transplantation patients with pulmonary fibrosis. Ann. Thorac. Surg.88(6), 1757–1764 (2009).
   PubMed Web of Science ®Google Scholar
• Russo MJ, Iribarne A, Hong KN et al. High lung allocation score is associated with increased morbidity and mortality following transplantation. Chest137(3), 651–657 (2010).
   PubMed Web of Science ®Google Scholar
• Maurer JR, Frost AE, Estenne M, Higenbottam T, Glanville AR. International guidelines for the selection of lung transplant candidates. The International Society for Heart and Lung Transplantation the American Thoracic Society, the American Society of Transplant Physicians, the European Respiratory Society. J. Heart Lung Transplant.17(7), 703–709 (1998).
   PubMed Web of Science ®Google Scholar
• Mahidhara R, Bastani S, Ross DJ et al. Lung transplantation in older patients? J. Thorac. Cardiovasc. Surg.135(2), 412–420 (2008).
   PubMed Web of Science ®Google Scholar
• Vadnerkar A, Toyoda Y, Crespo M et al. Age-specific complications among lung transplant recipients 60 years and older. J. Heart Lung Transplant.30(3), 273–281 (2011).
   PubMedGoogle Scholar
• Smith PW, Wang H, Parini V et al. Lung transplantation in patients 60 years and older: results, complications, and outcomes. Ann. Thorac. Surg.82(5), 1835–1841 (2006).
   PubMedGoogle Scholar
• Weiss ES, Merlo CA, Shah AS. Impact of advanced age in lung transplantation: an analysis of United Network for Organ Sharing data. J. Am. Coll. Surg.208(3), 400–409 (2009).
   PubMedGoogle Scholar
• Gutierrez C, Al-Faifi S, Chaparro C et al. The effect of recipient’s age on lung transplant outcome. Am. J. Transplant.7(5), 1271–1277 (2007).
   PubMed Web of Science ®Google Scholar
• Fried LP, Tangen CM, Walston J et al. Frailty in older adults: evidence for a phenotype. J. Gerontol. A Biol. Sci. Med. Sci.56(3), M146–M156 (2001).
   PubMed Web of Science ®Google Scholar
• Fried LP, Xue QL, Cappola AR et al. Nonlinear multisystem physiological dysregulation associated with frailty in older women: implications for etiology and treatment. J. Gerontol. A Biol. Sci. Med. Sci.64(10), 1049–1057 (2009).
   PubMed Web of Science ®Google Scholar
• Abellan van Kan G, Rolland Y, Andrieu S et al. Gait speed at usual pace as a predictor of adverse outcomes in community-dwelling older people an International Academy on Nutrition and Aging (IANA) Task Force. J. Nutr. Health Aging13(10), 881–889 (2009).
   PubMed Web of Science ®Google Scholar
• Graham JE, Snih SA, Berges IM, Ray LA, Markides KS, Ottenbacher KJ. Frailty and 10-year mortality in community-living Mexican American older adults. Gerontology55(6), 644–651 (2009).
   PubMed Web of Science ®Google Scholar
• Purser JL, Kuchibhatla MN, Fillenbaum GG, Harding T, Peterson ED, Alexander KP. Identifying frailty in hospitalized older adults with significant coronary artery disease. J. Am. Geriatr. Soc.54(11), 1674–1681 (2006).
   PubMed Web of Science ®Google Scholar
• Boxer R, Kleppinger A, Ahmad A, Annis K, Hager D, Kenny A. The 6-minute walk is associated with frailty and predicts mortality in older adults with heart failure. Congest. Heart Fail.16(5), 208–213 (2010).
   PubMedGoogle Scholar
• Cacciatore F, Abete P, Mazzella F et al. Frailty predicts long-term mortality in elderly subjects with chronic heart failure. Eur. J. Clin. Invest.35(12), 723–730 (2005).
   PubMed Web of Science ®Google Scholar
• Johansen KL, Chertow GM, Jin C, Kutner NG. Significance of frailty among dialysis patients. J. Am. Soc. Nephrol.18(11), 2960–2967 (2007).
   PubMed Web of Science ®Google Scholar
• Franceschi C, Capri M, Monti D et al. Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech. Ageing Dev.128(1), 92–105 (2007).
   PubMed Web of Science ®Google Scholar
• Leng S, Chaves P, Koenig K, Walston J. Serum interleukin-6 and hemoglobin as physiological correlates in the geriatric syndrome of frailty: a pilot study. J. Am. Geriatr. Soc.50(7), 1268–1271 (2002).
   PubMed Web of Science ®Google Scholar
• Ferrucci L, Penninx BW, Volpato S et al. Change in muscle strength explains accelerated decline of physical function in older women with high interleukin-6 serum levels. J. Am. Geriatr. Soc.50(12), 1947–1954 (2002).
   PubMed Web of Science ®Google Scholar
• Visser M, Pahor M, Taaffe DR et al. Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study. J. Gerontol. A Biol. Sci. Med. Sci.57(5), M326–M332 (2002).
   PubMed Web of Science ®Google Scholar
• Hoffman SA, Wang L, Shah CV et al. Plasma cytokines and chemokines in primary graft dysfunction post-lung transplantation. Am. J. Transplant.9(2), 389–396 (2009).
   PubMed Web of Science ®Google Scholar
• Moreno I, Vicente R, Ramos F, Vicente JL, Barbera M. Determination of interleukin-6 in lung transplantation: association with primary graft dysfunction. Transplant. Proc.39(7), 2425–2426 (2007).
   PubMedGoogle Scholar
• Mathur A, Baz M, Staples ED et al. Cytokine profile after lung transplantation: correlation with allograft injury. Ann. Thorac. Surg.81(5), 1844–1849 (2006).
   PubMedGoogle Scholar
• Rolfe MW, Kunkel SL, Demeester SR et al. Expression of interleukin-6 in association with rat lung reimplantation and allograft rejection. Am. Rev. Respir. Dis.147(4), 1010–1016 (1993).
   PubMedGoogle Scholar
• Pham SM, Yoshida Y, Aeba R et al. Interleukin-6, a marker of preservation injury in clinical lung transplantation. J. Heart Lung Tranpslant.11(6), 1017–1024 (1992).
   PubMedGoogle Scholar
• Kaneda H, Waddell TK, de Perrot M et al. Pre-implantation multiple cytokine mRNA expression analysis of donor lung grafts predicts survival after lung transplantation in humans. Am. J. Transplant.6(3), 544–551 (2006).
   PubMedGoogle Scholar
• Iacono A, Dauber J, Keenan R et al. Interleukin 6 and interferon-gamma gene expression in lung transplant recipients with refractory acute cellular rejection: implications for monitoring and inhibition by treatment with aerosolized cyclosporine. Transplantation64(2), 263–269 (1997).
   PubMed Web of Science ®Google Scholar
• Magnan A, Mege JL, Escallier JC et al. Balance between alveolar macrophage IL-6 and TGF-beta in lung-transplant recipients. Marseille and Montreal Lung Transplantation Group. Am. J. Respir. Crit. Care Med.153(4 Pt 1), 1431–1436 (1996).
   PubMedGoogle Scholar
• Yoshida Y, Iwaki Y, Pham S et al. Benefits of posttransplantation monitoring of interleukin 6 in lung transplantation. Ann. Thorac. Surg.55(1), 89–93 (1993).
   PubMedGoogle Scholar
• Nawrot TS, Vos R, Jacobs L et al. The impact of traffic air pollution on bronchiolitis obliterans syndrome and mortality after lung transplantation. Thorax66(9), 748–754 (2011).
   PubMed Web of Science ®Google Scholar
• Lu KC, Jaramillo A, Lecha RL et al. Interleukin-6 and interferon-gamma gene polymorphisms in the development of bronchiolitis obliterans syndrome after lung transplantation. Transplantation74(9), 1297–1302 (2002).
   PubMedGoogle Scholar
• Scholma J, Slebos DJ, Boezen HM et al. Eosinophilic granulocytes and interleukin-6 level in bronchoalveolar lavage fluid are associated with the development of obliterative bronchiolitis after lung transplantation. Am. J. Respir. Crit. Care Med.162(6), 2221–2225 (2000).
   PubMedGoogle Scholar
• Schmaltz HN, Fried LP, Xue QL, Walston J, Leng SX, Semba RD. Chronic cytomegalovirus infection and inflammation are associated with prevalent frailty in community-dwelling older women. J. Am. Geriatr. Soc.53(5), 747–754 (2005).
   PubMed Web of Science ®Google Scholar
• Botha P, Trivedi D, Weir CJ et al. Extended donor criteria in lung transplantation: impact on organ allocation. J. Thorac. Cardiovasc. Surg.131(5), 1154–1160 (2006).
   PubMed Web of Science ®Google Scholar
• Pilcher DV, Snell GI, Scheinkestel CD, Bailey MJ, Williams TJ. High donor age, low donor oxygenation, and high recipient inotrope requirements predict early graft dysfunction in lung transplant recipients. J. Heart Lung Transplant.24(11), 1814–1820 (2005).
   PubMed Web of Science ®Google Scholar
• Veroux M, Grosso G, Corona D et al. Age is an important predictor of kidney transplantation outcome. Nephrol. Dial. Transplant. doi:10.1093/ndt/gfr524 (2011) (Epub ahead of print).
   PubMedGoogle Scholar
• Kwon OJ, Lee HG, Kwak JY. The impact of donor and recipient age on the outcome of kidney transplantation. Transplant. Proc.36(7), 2043–2045 (2004).
   PubMedGoogle Scholar
• Avolio AW, Cillo U, Salizzoni M et al. Balancing donor and recipient risk factors in liver transplantation: the value of D-MELD with particular reference to HCV recipients. Am. J. Transplant.11(12), 2724–2736 (2011).
   PubMed Web of Science ®Google Scholar
• Makary MA, Segev DL, Pronovost PJ et al. Frailty as a predictor of surgical outcomes in older patients. J. Am. Coll. Surg.210(6), 901–908 (2010).
   PubMed Web of Science ®Google Scholar
• Afilalo J, Eisenberg MJ, Morin JF et al. Gait speed as an incremental predictor of mortality and major morbidity in elderly patients undergoing cardiac surgery. J. Am. Coll. Cardiol.56(20), 1668–1676 (2010).
   PubMed Web of Science ®Google Scholar
• Lee JS, He K, Harbaugh CM et al. Frailty, core muscle size, and mortality in patients undergoing open abdominal aortic aneurysm repair. J. Vasc. Surg.53(4), 912–917 (2011).
   PubMed Web of Science ®Google Scholar
• Christie JD, Edwards LB, Aurora P et al. Registry of the International Society for Heart and Lung Transplantation: twenty-fifth official adult lung and heart/lung transplantation report – 2008. J. Heart Lung Transplant.27(9), 957–969 (2008).
   PubMed Web of Science ®Google Scholar
• Trulock EP, Christie JD, Edwards LB et al. Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult lung and heart-lung transplantation report – 2007. J. Heart Lung Transplant.26(8), 782–795 (2007).
   PubMed Web of Science ®Google Scholar
• Lederer DJ, Wilt JS, D’Ovidio F et al. Obesity and underweight are associated with an increased risk of death after lung transplantation. Am. J. Respir. Crit. Care Med.1(9), 887–895 (2009).
   Google Scholar
• Lederer DJ, Kawut SM, Wickersham N et al. Obesity and primary graft dysfunction after lung transplantation: the LTOG obesity study. Am. J. Respir. Crit. Care Med. doi:10.1164/rccm.201104-0728OC (2011) (Epub ahead of print).
   Google Scholar
• Jain M, Budinger GR, Lo A et al. Leptin promotes fibroproliferative acute respiratory distress syndrome by inhibiting peroxisome proliferator-activated receptor-gamma. Am. J. Respir. Crit. Care Med.183(11), 1490–1498 (2011).
   PubMedGoogle Scholar
• Bellmeyer A, Martino JM, Chandel NS, Scott Budinger GR, Dean DA, Mutlu GM. Leptin resistance protects mice from hyperoxia-induced acute lung injury. Am. J. Respir. Crit. Care Med.175(6), 587–594 (2007).
   PubMed Web of Science ®Google Scholar
• Walston J, Hadley EC, Ferrucci L et al. Research agenda for frailty in older adults: toward a better understanding of physiology and etiology: summary from the American Geriatrics Society/National Institute on Aging Research Conference on Frailty in Older Adults. J. Am. Geriatr. Soc.54(6), 991–1001 (2006).
   PubMed Web of Science ®Google Scholar
• Englesbe MJ, Patel SP, He K et al. Sarcopenia and mortality after liver transplantation. J. Am. Coll. Surg.211(2), 271–278 (2010).
   PubMed Web of Science ®Google Scholar
• Streja E, Molnar MZ, Kovesdy CP et al. Associations of pretransplant weight and muscle mass with mortality in renal transplant recipients. Clin. J. Am. Soc. Nephrol.6(6), 1463–1471 (2011).
   PubMed Web of Science ®Google Scholar
• Oterdoom LH, van Ree RM, de Vries AP et al. Urinary creatinine excretion reflecting muscle mass is a predictor of mortality and graft loss in renal transplant recipients. Transplantation86(3), 391–398 (2008).
   PubMed Web of Science ®Google Scholar
• Swallow EB, Reyes D, Hopkinson NS et al. Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease. Thorax62(2), 115–120 (2007).
   PubMed Web of Science ®Google Scholar
• Marquis K, Debigare R, Lacasse Y et al. Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med.166(6), 809–813 (2002).
   PubMed Web of Science ®Google Scholar
• Soler-Cataluna JJ, Sanchez-Sanchez L, Martinez-Garcia MA, Sanchez PR, Salcedo E, Navarro M. Mid-arm muscle area is a better predictor of mortality than body mass index in COPD. Chest128(4), 2108–2115 (2005).
   PubMed Web of Science ®Google Scholar
• Slinde F, Gronberg A, Engstrom CP, Rossander-Hulthen L, Larsson S. Body composition by bioelectrical impedance predicts mortality in chronic obstructive pulmonary disease patients. Respir. Med.99(8), 1004–1009 (2005).
   PubMed Web of Science ®Google Scholar
• Mador MJ. Muscle mass, not body weight, predicts outcome in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med.166(6), 787–789 (2002).
   PubMed Web of Science ®Google Scholar
• Burdet L, de Muralt B, Schutz Y, Pichard C, Fitting JW. Administration of growth hormone to underweight patients with chronic obstructive pulmonary disease. A prospective, randomized, controlled study. Am. J. Respir. Crit. Care Med.156(6), 10–16 (1997).
   Google Scholar
• Johannsson G, Bengtsson BA, Ahlmen J. Double-blind, placebo-controlled study of growth hormone treatment in elderly patients undergoing chronic hemodialysis: anabolic effect and functional improvement. Am. J. Kidney Dis.33(4), 709–717 (1999).
   PubMed Web of Science ®Google Scholar
• Johansen KL, Painter PL, Sakkas GK, Gordon P, Doyle J, Shubert T. Effects of resistance exercise training and nandrolone decanoate on body composition and muscle function among patients who receive hemodialysis: a randomized, controlled trial. J. Am. Soc. Nephrol.17(8), 2307–2314 (2006).
   PubMed Web of Science ®Google Scholar
• Debigare R, Marquis K, Cote CH et al. Catabolic/anabolic balance and muscle wasting in patients with COPD. Chest124(1), 83–89 (2003).
   PubMed Web of Science ®Google Scholar
• Casaburi R, Bhasin S, Cosentino L et al. Effects of testosterone and resistance training in men with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med.170(8), 870–878 (2004).
   PubMed Web of Science ®Google Scholar
• Sharma S, Arneja A, McLean L et al. Anabolic steroids in COPD: a review and preliminary results of a randomized trial. Chron. Respir. Dis.5(3), 169–176 (2008).
   PubMedGoogle Scholar
• Le Cornu KA, McKiernan FJ, Kapadia SA, Neuberger JM. A prospective randomized study of preoperative nutritional supplementation in patients awaiting elective orthotopic liver transplantation. Transplantation69(7), 1364–1369 (2000).
   PubMedGoogle Scholar
• Andersson DC, Betzenhauser MJ, Reiken S et al. Ryanodine receptor oxidation causes intracellular calcium leak and muscle weakness in aging. Cell Metab.14(2), 196–207 (2011).
   PubMed Web of Science ®Google Scholar
• Bellinger AM, Reiken S, Dura M et al. Remodeling of ryanodine receptor complex causes ‘leaky’ channels: a molecular mechanism for decreased exercise capacity. Proc. Natl Acad. Sci. USA105(6), 2198–2202 (2008).
   PubMed Web of Science ®Google Scholar
• Haykowsky M, Taylor D, Kim D, Tymchak W. Exercise training improves aerobic capacity and skeletal muscle function in heart transplant recipients. Am. J. Transplant.9(4), 734–739 (2009).
   PubMed Web of Science ®Google Scholar
• Turchetta A, Salerno T, Lucidi V, Libera F, Cutrera R, Bush A. Usefulness of a program of hospital-supervised physical training in patients with cystic fibrosis. Pediatr. Pulmonol.38(2), 115–118 (2004).
   PubMedGoogle Scholar
• Cote CG, Celli BR. Pulmonary rehabilitation and the BODE index in COPD. Eur. Respir. J.26(4), 630–636 (2005).
   PubMed Web of Science ®Google Scholar
• Celli BR, Cote CG, Marin JM et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N. Engl. J. Med.350(10), 1005–1012 (2004).
   PubMed Web of Science ®Google Scholar
• Titman A, Rogers CA, Bonser RS, Banner NR, Sharples LD. Disease-specific survival benefit of lung transplantation in adults: a national cohort study. Am. J. Transplant.9(7), 1640–1649 (2009).
   PubMed Web of Science ®Google Scholar
• Hosenpud J, Bennett LE, Keck BM, Edwards EB, Novick RJ. Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease. Lancet351, 24–27 (1998).
   PubMed Web of Science ®Google Scholar
• Thabut G, Ravaud P, Christie JD et al. Determinants of the survival benefit of lung transplantation in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med.177(10), 1156–1163 (2008).
   PubMed Web of Science ®Google Scholar
• Lamas DJ, Kawut SM, Bagiella E, Philip N, Arcasoy SM, Lederer DJ. Delayed access and survival in idiopathic pulmonary fibrosis: a cohort study. Am. J. Respir. Crit. Care Med.184(7), 842–847 (2011).
   PubMed Web of Science ®Google Scholar
• Chen H, Shiboski SC, Golden JA et al. Impact of the lung allocation score on lung transplantation for pulmonary arterial hypertension. Am. J. Respir. Crit. Care Med.1(5), 468–474 (2009).
   Google Scholar
• Benza RL, Miller DP, Gomberg-Maitland M et al. Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL). Circulation122(2), 164–172 (2010).
   PubMed Web of Science ®Google Scholar
• Mereles D, Ehlken N, Kreuscher S et al. Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. Circulation114(14), 1482–1489 (2006).
   PubMed Web of Science ®Google Scholar